BD introduces 2nd gen BD Nano pen needle technology to help optimize injection technique

14:57 EST 28 Jan 2019 | PharmaBiz

BD (Becton, Dickinson and Company), a leading global medical technology company, announced the US Food and Drug Administration 510(k) clearance of its second generation BD Nano pen needle, designed

More From BioPortfolio on "BD introduces 2nd gen BD Nano pen needle technology to help optimize injection technique"